Fate Therapeutics Inc. (FATE) Dropped -7.58% or -0.99 To Price $12.07 On Tuesday

Fate Therapeutics Inc. (FATE) dropped -7.58% or -0.99 to $12.07. It is near to 906461 shares traded, which is 103.01% compare to the average total volume 880010. The market cap of FATE is $636.92 million. The year to date change is 107.3%. The 52 week price range is from $2.52 to $14.45. Price of FATE have changed 0.00% during last week. It have changed 67.44% over last month, 194.48% over last 3 months, N/A and 158.61% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for FATE is 9.02. It is -25.27% below current price. The 200-day Moving Averages for FATE is 5.09. It is -57.83% below current price. The 52-week High is 14.45. It is 19.72% from the current price. The 52-week Low is 2.52. It is -79.12% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of FATE is 3.12 on 2018-02-28. Short % to float is 4.41%. There are some statistics of FATE. It is has market cap $636.92 million. The share outstanding is 52.77 million. The average volume is 880010. The revenue is 3.08M. It has 222.53M cash and 30.17M in debt. The percent of top 15 Institution holding is 48.10%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of FATE is -57.14%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of FATE is -42.88%.


Share this post